Atlas Trials

A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers

Clinical trial NCT01545570 · COMPLETED

Trial details

NCT number
NCT01545570
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2011-11-07
Primary completion
2012-12-23
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.